A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)M.B. Long, James D. Chalmers, Hollian Richardson et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 8
Treatment with the dipeptidyl peptidase-1 inhibitor brensocatib increases the antimicrobial peptide secretory leukocyte peptidase inhibitor (SLPI) in patients with bronchiectasis: results from the WILLOW trialLídia Perea, James D. Chalmers, Emma Johnson et al.|Unknown|2023Cited by 0